20th International Congress » Therapy in movement disorders: Gene and cell-based therapies

Date: Tuesday, June 21, 2016

Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Session Type: Poster Session

Meeting: 20th International Congress

12:30pm-2:00pm: A descriptive study on the safety and feasibility of mesenchymal stem cell therapy for Parkinson’s disease: A case series

M.J.O.V. Buensalido, J.J.A. Tiongson (Pasig City, Philippines)

12:30pm-2:00pm: Characterisation of the A30P mutation in alpha-synuclein gene in patient-derived cellular model of Parkinson’s disease

B.F.R. Santos, P.A. Barbuti, I. Boussaad, A. Hummel, R. Krüger (Belval, Luxembourg)

12:30pm-2:00pm: Clinical and neuroimaging outcomes up to 18 years after fetal tissue transplant for Parkinson’s disease

C. Henchcliffe, J. Carter, A. Hanineva, Y. Kang, J. Babich, S.M. Gollomp, A.P. Strafella, A. Fasano, L.D. Ravdin, N. Hellmers, C. McRae (New York, NY, USA)

12:30pm-2:00pm: Comparison of two protocols for neural induction and cultivation of iPSCs derived neural stem cells

M.G. Pauly, P. Capetian, B. Meier, V. Krajka, F. Stengel, P. Seibler, C. Klein (Lübeck, Germany)

12:30pm-2:00pm: Differentiated versus undifferentiated mesenchymal stem cell therapy in paraquat model of Parkinson’s disease

S.I. El-Jaafary, H.S. Abdel Tawab, M.Y. Elwash, H. Gabr, H.M. Saad Eldien (Cairo, Egypt)

12:30pm-2:00pm: Functional characterisation and the selective vulnerability of SNCA (A30P) patient-derived midbrain dopaminergic neurons to ER stress

P.A. Barbuti, B.F.R. Santos, S. Delcambre, Y. Nonnenmacher, C.D. Obermaier, A. Hummel, K. Hiller, R. Krueger (Belvaux, Luxembourg)

12:30pm-2:00pm: Gene delivery of AAV2-neurturin for patients with Parkinson’s disease: A meta-analysis

A.G. Almraezy, H. Ahmed, M. Elnenny, A. Negida (Cairo, Egypt)

12:30pm-2:00pm: Generation of human induced pluripotent stem cells carrying a safety bet for cell-based therapy in Parkinson’s disease

Y. Kimura, Y. Kanemura, T. Shofuda, M. Onodera, M. Oda, M. Nakamori, T. Nakano, H. Mochizuki (Osaka, Japan)

12:30pm-2:00pm: Parkinson’s disease-associated Miro1 mutants cause mitochondrial dysfunction

D. Grossmann, D. Scheibner, J. Fitzgerald, W. Mätzler, L. Burbulla, R. Krüger (Belvaux, Luxembourg)

12:30pm-2:00pm: Polyethylenimine (PEI) nanoparticle-mediated delivery of siRNA to silence neuronal gene expression of alpha-synuclein in a mouse model of Parkinson’s disease

C. Helmschrodt, A. Bauer, S. Höbel, S. Schöniger, S.A. Fietz, A. Aigner, A. Richter, F. Richter (Leipzig, Germany)

12:30pm-2:00pm: Two-step induction of dopaminergic neurons – Differentiation of leukapharesis-derived mesenchymal stem cells

S.I. El-Jaafary, M.M. Abdel-Dayem, N.M. Salama, H. Gabr, A.S. Abdelhafiz, Z.M. Ismail (Cairo, Egypt)

12:30pm-2:00pm: Unconventional chaperone inhibits alpha-synuclein amyloid formation by promoting off-pathway aggregation

J. Bieschke, E. Illes-Toth, M. Shah, N. Wu, S. Verzini, P. Selenko, E. Wanker (Saint Louis, MO, USA)

« View all sessions from the 20th International Congress.